Modern Healthspan: SGLT2 Inhibitors: Longevity Therapeutics, Senolytics & Telomere Lengthening #shorts
M Modern Healthspan Video Summary · April 26, 2026 View Full Protocol → Key Takeaways SGLT2 inhibitors like canagliflozin and henagliflozin may act as longevity therapeutics by clearing senescent cells and protecting DNA. Henagliflozin was shown in a 26-week trial to lengthen telomeres in 90% of participants, suggesting DNA protection benefits. These drugs are now…
